30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512552
319423
2

1 gen 1998 anni - Trastuzumab

Descrizione:

For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.

Aggiunto al nastro di tempo:

14 nov 2019

Data:

1 gen 1998 anni
Adesso
~ 26 years ago